Whale Team

[QuicKtip]

New Growth Report BioStem Technologies, Inc. (OTC: $BSEM)

BSEM Key Highlights


Completed an extensive two-year audit in preparation for moving BSEM to a national exchange. (NASDAQ or NYSE)
Recently released their Q1 earnings, which shocked the market with revenues totaling $41 million in the first quarter of 2024.
First positive net income of over $4.4 million in the quarter.
Analyst Target $23.75 representing a 153% upside from the current price of $9.38
Regenerative medicine leverages the body's natural systems to rebuild tissues and organs. It is expected to revolutionize healthcare, with the global stem cell market projected to reach $18.4 billion by 2028.

Take a minute to look at the full analysis and disclosures >>> https://tradersnewssource.com/wp-content/uploads/2024/06/TNS-BSEM-growth-report-6-27-24.pdf